Intratracheal injection of LPA2 agonists reverses the increased airway hyperresponsiveness and eosinophilia in sPLA2-III-null mice, suggesting that sPLA2-III constrains allergen-induced asthma by driving tissue-protective epithelial LPA2 signaling. This evidence concerns the gene PLA2G3 and Increased total eosinophil count.